Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Roselli

Showing results (151-160 of 164) with videos related to

Pageof 17
Sort By:
Cancers|August 27, 2021
Urine LOX-1 and Volatilome as Promising Tools towards the Early Detection of Renal CancerMichela Murdocca, Francesco Torino, Sabina Pucci, et al.
Cancers|August 26, 2022
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-AnalysisValentina Russo, Eleonora Lallo, Armelle Munnia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2024
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer: Phase III ERMES StudyCarmine Pinto, Armando Orlandi, Nicola Normanno, et al.
International Journal of Cancer|October 8, 2008
Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patientsPaola Nisticò, Imerio Capone, Belinda Palermo, et al.
Pharmacogenomics|December 19, 2014
Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factorsDavid Della-Morte, Raffaele Palmirotta, Ashish K Rehni, et al.
Molecular Oncology|July 10, 2021
Global mapping of cancers: The Cancer Genome Atlas and beyondCarlo Ganini, Ivano Amelio, Riccardo Bertolo, et al.
Tumori|December 24, 2016
Position paper of the Italian Association of Medical Oncology on early palliative care in oncology practice (Simultaneous Care)Vittorina Zagonel, Vittorio Franciosi, Antonella Brunello, et al.
The Lancet. Oncology|March 14, 2020
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trialChiara Cremolini, Carlotta Antoniotti, Daniele Rossini, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 11, 2020
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER StudyGiulia Bon, Laura Pizzuti, Valentina Laquintana, et al.
Scientific Reports|July 3, 2021
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trialLaura Pizzuti, Maddalena Barba, Marco Mazzotta, et al.
Pageof 17

Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
Cancers|August 27, 2021
Urine LOX-1 and Volatilome as Promising Tools towards the Early Detection of Renal CancerMichela Murdocca, Francesco Torino, Sabina Pucci, et al.
Cancers|August 26, 2022
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-AnalysisValentina Russo, Eleonora Lallo, Armelle Munnia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2024
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer: Phase III ERMES StudyCarmine Pinto, Armando Orlandi, Nicola Normanno, et al.
International Journal of Cancer|October 8, 2008
Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patientsPaola Nisticò, Imerio Capone, Belinda Palermo, et al.
Pharmacogenomics|December 19, 2014
Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factorsDavid Della-Morte, Raffaele Palmirotta, Ashish K Rehni, et al.
Molecular Oncology|July 10, 2021
Global mapping of cancers: The Cancer Genome Atlas and beyondCarlo Ganini, Ivano Amelio, Riccardo Bertolo, et al.
Tumori|December 24, 2016
Position paper of the Italian Association of Medical Oncology on early palliative care in oncology practice (Simultaneous Care)Vittorina Zagonel, Vittorio Franciosi, Antonella Brunello, et al.
The Lancet. Oncology|March 14, 2020
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trialChiara Cremolini, Carlotta Antoniotti, Daniele Rossini, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 11, 2020
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER StudyGiulia Bon, Laura Pizzuti, Valentina Laquintana, et al.
Scientific Reports|July 3, 2021
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trialLaura Pizzuti, Maddalena Barba, Marco Mazzotta, et al.
Pageof 17